Selected research
Industry Research
RNA Synthesis Industry Research Report 2026
Market perspective
The global RNA Synthesis market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the RNA Synthesis market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the RNA Synthesis market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the RNA Synthesis market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of RNA Synthesis include GenScript, Hokkaido System Science, Bio-Synthesis, IDT, Thermo Fisher Scientific, Genewiz, Gene Universal, TriLink BioTechnologies and GE Healthcare Dharmacon, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global RNA Synthesis market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to RNA Synthesis.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
RNA Synthesis Market by Company
GenScript
Hokkaido System Science
Bio-Synthesis
IDT
Thermo Fisher Scientific
Genewiz
Gene Universal
TriLink BioTechnologies
GE Healthcare Dharmacon
ChemGenes
Creative Biolabs
Glen Research
VeliterBio
Creative Biogene
Merck
Eurofins Scientific
RNA Synthesis Segment by Type
mRNA Synthesis
tRNA Synthesis
rRNA Synthesis
siRNA Synthesis
RNA Synthesis Segment by Application
Biomedical Science
Pharmaceutical
Others
RNA Synthesis Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global RNA Synthesis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of RNA Synthesis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of RNA Synthesis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of RNA Synthesis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- mRNA Synthesis
- tRNA Synthesis
- rRNA Synthesis
- siRNA Synthesis
Applications
- Biomedical Science
- Pharmaceutical
- Others
Companies covered
- GenScript
- Hokkaido System Science
- Bio-Synthesis
- IDT
- Thermo Fisher Scientific
- Genewiz
- Gene Universal
- TriLink BioTechnologies
- GE Healthcare Dharmacon
- ChemGenes
- Creative Biolabs
- Glen Research
- VeliterBio
- Creative Biogene
- Merck
- Eurofins Scientific
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 RNA Synthesis by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 mRNA Synthesis
- 2.2.3 tRNA Synthesis
- 2.2.4 rRNA Synthesis
- 2.2.5 siRNA Synthesis
- 2.3 RNA Synthesis by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Biomedical Science
- 2.3.3 Pharmaceutical
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 RNA Synthesis Breakdown Data by Type
- 3.1 Global RNA Synthesis Historic Market Size by Type (2021-2026)
- 3.2 Global RNA Synthesis Forecasted Market Size by Type (2027-2032)
4 RNA Synthesis Breakdown Data by Application
- 4.1 Global RNA Synthesis Historic Market Size by Application (2021-2026)
- 4.2 Global RNA Synthesis Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global RNA Synthesis Market Perspective (2021-2032)
- 5.2 Global RNA Synthesis Growth Trends by Region
- 5.2.1 Global RNA Synthesis Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 RNA Synthesis Historic Market Size by Region (2021-2026)
- 5.2.3 RNA Synthesis Forecasted Market Size by Region (2027-2032)
- 5.3 RNA Synthesis Market Dynamics
- 5.3.1 RNA Synthesis Industry Trends
- 5.3.2 RNA Synthesis Market Drivers
- 5.3.3 RNA Synthesis Market Challenges
- 5.3.4 RNA Synthesis Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top RNA Synthesis Players by Revenue
- 6.1.1 Global Top RNA Synthesis Players by Revenue (2021-2026)
- 6.1.2 Global RNA Synthesis Revenue Market Share by Players (2021-2026)
- 6.2 Global RNA Synthesis Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of RNA Synthesis Head Office and Area Served
- 6.4 Global RNA Synthesis Players, Product Type & Application
- 6.5 Global RNA Synthesis Manufacturers Established Date
- 6.6 Global RNA Synthesis Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America RNA Synthesis Market Size (2021-2032)
- 7.2 North America RNA Synthesis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America RNA Synthesis Market Size by Country (2021-2026)
- 7.4 North America RNA Synthesis Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe RNA Synthesis Market Size (2021-2032)
- 8.2 Europe RNA Synthesis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe RNA Synthesis Market Size by Country (2021-2026)
- 8.4 Europe RNA Synthesis Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific RNA Synthesis Market Size (2021-2032)
- 9.2 Asia-Pacific RNA Synthesis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific RNA Synthesis Market Size by Country (2021-2026)
- 9.4 Asia-Pacific RNA Synthesis Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America RNA Synthesis Market Size (2021-2032)
- 10.2 South America RNA Synthesis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America RNA Synthesis Market Size by Country (2021-2026)
- 10.4 South America RNA Synthesis Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa RNA Synthesis Market Size (2021-2032)
- 11.2 Middle East & Africa RNA Synthesis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa RNA Synthesis Market Size by Country (2021-2026)
- 11.4 Middle East & Africa RNA Synthesis Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 GenScript
- 12.1.1 GenScript Company Information
- 12.1.2 GenScript Business Overview
- 12.1.3 GenScript Revenue in RNA Synthesis Business (2021-2026)
- 12.1.4 GenScript RNA Synthesis Product Portfolio
- 12.1.5 GenScript Recent Developments
- 12.2 Hokkaido System Science
- 12.2.1 Hokkaido System Science Company Information
- 12.2.2 Hokkaido System Science Business Overview
- 12.2.3 Hokkaido System Science Revenue in RNA Synthesis Business (2021-2026)
- 12.2.4 Hokkaido System Science RNA Synthesis Product Portfolio
- 12.2.5 Hokkaido System Science Recent Developments
- 12.3 Bio-Synthesis
- 12.3.1 Bio-Synthesis Company Information
- 12.3.2 Bio-Synthesis Business Overview
- 12.3.3 Bio-Synthesis Revenue in RNA Synthesis Business (2021-2026)
- 12.3.4 Bio-Synthesis RNA Synthesis Product Portfolio
- 12.3.5 Bio-Synthesis Recent Developments
- 12.4 IDT
- 12.4.1 IDT Company Information
- 12.4.2 IDT Business Overview
- 12.4.3 IDT Revenue in RNA Synthesis Business (2021-2026)
- 12.4.4 IDT RNA Synthesis Product Portfolio
- 12.4.5 IDT Recent Developments
- 12.5 Thermo Fisher Scientific
- 12.5.1 Thermo Fisher Scientific Company Information
- 12.5.2 Thermo Fisher Scientific Business Overview
- 12.5.3 Thermo Fisher Scientific Revenue in RNA Synthesis Business (2021-2026)
- 12.5.4 Thermo Fisher Scientific RNA Synthesis Product Portfolio
- 12.5.5 Thermo Fisher Scientific Recent Developments
- 12.6 Genewiz
- 12.6.1 Genewiz Company Information
- 12.6.2 Genewiz Business Overview
- 12.6.3 Genewiz Revenue in RNA Synthesis Business (2021-2026)
- 12.6.4 Genewiz RNA Synthesis Product Portfolio
- 12.6.5 Genewiz Recent Developments
- 12.7 Gene Universal
- 12.7.1 Gene Universal Company Information
- 12.7.2 Gene Universal Business Overview
- 12.7.3 Gene Universal Revenue in RNA Synthesis Business (2021-2026)
- 12.7.4 Gene Universal RNA Synthesis Product Portfolio
- 12.7.5 Gene Universal Recent Developments
- 12.8 TriLink BioTechnologies
- 12.8.1 TriLink BioTechnologies Company Information
- 12.8.2 TriLink BioTechnologies Business Overview
- 12.8.3 TriLink BioTechnologies Revenue in RNA Synthesis Business (2021-2026)
- 12.8.4 TriLink BioTechnologies RNA Synthesis Product Portfolio
- 12.8.5 TriLink BioTechnologies Recent Developments
- 12.9 GE Healthcare Dharmacon
- 12.9.1 GE Healthcare Dharmacon Company Information
- 12.9.2 GE Healthcare Dharmacon Business Overview
- 12.9.3 GE Healthcare Dharmacon Revenue in RNA Synthesis Business (2021-2026)
- 12.9.4 GE Healthcare Dharmacon RNA Synthesis Product Portfolio
- 12.9.5 GE Healthcare Dharmacon Recent Developments
- 12.10 ChemGenes
- 12.10.1 ChemGenes Company Information
- 12.10.2 ChemGenes Business Overview
- 12.10.3 ChemGenes Revenue in RNA Synthesis Business (2021-2026)
- 12.10.4 ChemGenes RNA Synthesis Product Portfolio
- 12.10.5 ChemGenes Recent Developments
- 12.11 Creative Biolabs
- 12.11.1 Creative Biolabs Company Information
- 12.11.2 Creative Biolabs Business Overview
- 12.11.3 Creative Biolabs Revenue in RNA Synthesis Business (2021-2026)
- 12.11.4 Creative Biolabs RNA Synthesis Product Portfolio
- 12.11.5 Creative Biolabs Recent Developments
- 12.12 Glen Research
- 12.12.1 Glen Research Company Information
- 12.12.2 Glen Research Business Overview
- 12.12.3 Glen Research Revenue in RNA Synthesis Business (2021-2026)
- 12.12.4 Glen Research RNA Synthesis Product Portfolio
- 12.12.5 Glen Research Recent Developments
- 12.13 VeliterBio
- 12.13.1 VeliterBio Company Information
- 12.13.2 VeliterBio Business Overview
- 12.13.3 VeliterBio Revenue in RNA Synthesis Business (2021-2026)
- 12.13.4 VeliterBio RNA Synthesis Product Portfolio
- 12.13.5 VeliterBio Recent Developments
- 12.14 Creative Biogene
- 12.14.1 Creative Biogene Company Information
- 12.14.2 Creative Biogene Business Overview
- 12.14.3 Creative Biogene Revenue in RNA Synthesis Business (2021-2026)
- 12.14.4 Creative Biogene RNA Synthesis Product Portfolio
- 12.14.5 Creative Biogene Recent Developments
- 12.15 Merck
- 12.15.1 Merck Company Information
- 12.15.2 Merck Business Overview
- 12.15.3 Merck Revenue in RNA Synthesis Business (2021-2026)
- 12.15.4 Merck RNA Synthesis Product Portfolio
- 12.15.5 Merck Recent Developments
- 12.16 Eurofins Scientific
- 12.16.1 Eurofins Scientific Company Information
- 12.16.2 Eurofins Scientific Business Overview
- 12.16.3 Eurofins Scientific Revenue in RNA Synthesis Business (2021-2026)
- 12.16.4 Eurofins Scientific RNA Synthesis Product Portfolio
- 12.16.5 Eurofins Scientific Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst